with 10 million which includes the tax rebate your EV is around 9 million for a drug that compared to AGN is far superior in its mode of action and mono therapy. AGN was at a 70 million market cap in the same position right now as NYR. To be honest it’s actually significantly undervalued and 45 cents target price is more realistic which it was trading at before any drug was working
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.070(25.0%) |
Mkt cap ! $73.82M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 35.0¢ | 28.5¢ | $423.1K | 1.316M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 20970 | 2 |
View Market Depth
| Last trade - 16.17pm 21/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |